Editor's Pick HopeLab's six free-to-play online minigames help kids understand why they need to take medicine that makes them feel sick.
Syros Pharmaceuticals integrates gene control research and drug discovery with disease biology and genomic data. Its initial focus is on cancer, but the platform will be applicable to other areas in the future.
Bina's platform significantly reduces the time and cost of processing the human genome, which has far-reaching implications for the world of healthcare.
Editor's Pick Ayasdi is working with the nation's top hospitals and medical researchers to uncover more targeted treatments for disease.
Molecular information company Foundation Medicine raises $42.5M to improve cancer treatment
You’re as likely to get cancer from using your cell phone as from drinking coffee. Say what? That’s right, cell phone radiation is not dangerous.
The results of a an 18-year study by researchers in Denmark, tracked the incidence of …
Cell phone radiation might be carcinogenic — meaning the radiation could be linked to some cases of cancer — according to a panel assembled by the World Health Organization (WHO) to study the effects of the devices.
The WHO’s International …
A former Facebook president’s pet project for philanthropy, Causes, is coming into its own, announcing today it has closed a $9 million round of mezzanine funding.
The for-profit Causes bills itself as “tactical philanthropy,” leveraging Facebook and other social networking …
Mirna Thera spins out of Asuragen with $3M (release)
Stroke-therapy startup CoAxia raises $12M (release)
Stealthy device maker Synvascular gets $6.5M (peHUB)
AndroScience seeks $3.5M for anti-testosterone drugs (VentureWire)
Austria’s ProtAffin takes in €1.1M grant (release)
Cantimer takes in $2M for dehydration diagnostics (VentureWire)
Recodagen launches, takes aim at cancer (release)
Juniper Diagnostics spins out of ChemSensing (VentureWire)
Cantimer takes in $2M for dehydration diagnostics –The mystery of Menlo Park, Calif.-based Cantimer has …
Affinergy gets $3M in grants for biological “linkers” (release)
Specialty pharma EUSA raises $50M, spends $23M for public biotech Cytogen (release)
Calderome takes in $12M for cancer diagnostics (peHUB)
Pulse Health raises $2M for handheld free-radical device (release)
(UPDATED: See below.)
Another one bites the dust.
The saga of Precision Therapeutics, a Pittsburgh biotech developing what struck me last August as a particularly crude type of cancer-chemotherapy diagnostic, continues apace. In a tersely worded press release, the …
Precision Thera merger with “blank check” Oracle Healthcare collapses (release)
Sleep Solutions takes in $21M for sleep-apnea diagnostics (release)
Trevena takes in $24M for drugs targeting G-proteins (release)
“Specialty biotech” PanGenetics gets €23M for antibody drugs (release) Cancer-drug
RNAi developer PhaseRx gets $4M of a pledged $19M (Seattle Times)
TyRx Pharma, drug-device combo maker, raises $25M (release)
Agennix aims at $40M for cancer drugs (VentureWire)
Starr Life Sciences goes after $1.6M for small-animal vital-signs scanner (VW)
InSound Medical raises $11M for “invisible” hearing aids (VBLS exclusive)
Corventis takes in $20M for heart-failure therapy (VBLS exclusive)
Molecular diagnostics user AssureRx raises $1M (Cincinnati Enquirer)
Arresto Biosciences, cancer-drug developer, raises funds (VentureWire)
San Diego’s Obalon raises
PEAK Surgical takes in $21M for electrosurgical tools (release)
CellGate acquired by Australian cancer biotech ProGen for $2.5M (release)
Traversa raises $2M for RNAi-delivery technologies (release)
RemitDATA, Web-based healthcare-service co., takes in $5.5M (bizjournals.com)
Spinal-implant maker Archus Orthopedics
Health-info site HealthCentral Network pulls in $50M (paidContent)
BrightHeart Vet corrals $29M to acquire animal hospitals (release)
AviaraDx raises $8M for cancer diagnostics (peHUB)
Valor Medical aims for $15M for brain-aneurysm treatment (VentureWire)
IPC, inpatient-care provider, raises as
Satoris gets $5M for Alzheimer’s test (VentureWire)
Endotis Pharma pulls in €25M for clot-busting and cancer drugs (release)
Germany’s Direvo Biotech strikes drug-development pact with MedImmune (release)
OrthoAccel gets $1.3M for device to speed orthodonture (VW)
Autonomic Technologies raises $3M for neurostimulators (PE Hub)
Canopy Financial raises $15M for outsourced healthcare management (release)
Cancer-drug developer AmpliMed draws $5M (PE Hub)
Caprotec Bioanalytics receives €6M for protein-analysis tech (release)
ProtAffin draws additional €1.4M for anti-inflammatory
Alder Biopharmaceuticals, a Bothell, Wash., developer of antibody drugs, raised $40 million in a third funding round. Investors included Delphi Ventures, TPG Biotech, Sevin Rosen Funds, Ventures West, H.I.G. Ventures, and WRF Capital.
Alder develops antibody-based drugs for inflammation and …